Nabla Bio
MA - CambridgeBiotechnology
Focus: Nabla Bio is an antibody design-focused biotechnology company headquartered in Cambridge, MA, specializing in oncology therapeutics. The company appears to be in early-stage development with no public pipeline disclosure.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Open Jobs
13+1 this month
Stable — net +1 jobs in 30d
8 added, 7 removed. Backfill posture.
Should You Work at Nabla Bio?
AI assessmentNabla Bio is a high-risk, early-stage platform play best suited for scientists seeking deep technical ownership in antibody design, not career stability or near-term milestone catalysts.
Why Work Here
- Pure-play antibody design platform in oncology offers deep technical specialization for drug discovery and engineering professionals
- Cambridge biotech hub location provides access to top talent and collaboration with academic research centers
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Nabla Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.